Benjamin Hofner
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026.
Journal: Allergy
Published: May 22, 2026
Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.
Journal: Pharmaceutical statistics
Published: March 28, 2025
Clinical trials with interim analyses: standardizing terminology to increase clarity.
Journal: Trials
Published: November 30, 2024
Marketing authorisation for rare diseases: The European regulatory perspective using the example of gene and cell therapies
Journal: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
Published: July 30, 2024
Adaptive platform trials: the impact of common controls on type one error and power.
Journal: Journal of biopharmaceutical statistics
Published: November 22, 2023
Regulatory Issues of Platform Trials: Learnings from EU-PEARL.
Journal: Clinical pharmacology and therapeutics
Published: October 19, 2023
Publisher Correction: Optimizing the dynamics of protein expression.
Journal: Scientific reports
Published: April 05, 2020
Stochastic Dispersal Rather Than Deterministic Selection Explains the Spatio-Temporal Distribution of Soil Bacteria in a Temperate Grassland.
Journal: Frontiers in microbiology
Published: February 03, 2020
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 18, 2019
Last Updated: 09/26/2026